Bone Cysts: Clinical Trials

14 trials for Bone Cysts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 214Completed 14
Phase 12Completed 2

Follow Bone Cysts: new trials by email Literature Review of Bone Cysts trials Research Report on Bone Cysts

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
PTX-022, Vehicle comparator - BCCs in Gorlin Syndrome Patients
Phase 2CompletedPalvella Therapeutics, Inc.732021-05-062024-08-29
Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
ASN-002 - Basal Cell Carcinoma, Basal Cell Nevus Syndrome
Phase 2CompletedAscend Biopharmaceuticals Ltd212020-07-162024-04-10
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas
Patidegib, Vehicle gel - Basal Cell Carcinomas
Phase 2CompletedPellePharm, Inc.362016-11-112019-01-08
Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
Patidegib, Vehicle gel - Basal Cell Nevus Syndrome
Phase 2CompletedPellePharm, Inc.172016-06-062020-07-23
A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors
vismodegib - Keratocystic Odontogenic Tumor
Phase 2CompletedNYU College of Dentistry22015-10-272021-02-18
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm
Phase 1 / Phase 2CompletedAscend Biopharmaceuticals Ltd162015-09-012018-06-06
Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts
Denosumab (Xgeva) - Bone Cyst Aneurysmal, Pathological Fracture
Phase 1 / Phase 2CompletedPeking University People's Hospital62014-01-012018-01-30
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma
Carboplatin, Cognitive Assessment, Cyclophosphamide - Desmoplastic/Nodular Medulloblastoma, Medulloblastoma
Phase 2CompletedChildren's Oncology Group262013-12-242023-01-09
Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
Vismodegib, Aminolevulinic acid %20 topical solution - Basal Cell Nevus Syndrome, Gorlin's Syndrome
Phase 2CompletedUCSF Benioff Children's Hospital Oakland242012-04-012020-11-02
Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
LDE225, Placebo - Basal Cell Carcinoma, Gorlin Syndrome
Phase 2CompletedNovartis Pharmaceuticals102011-04-012015-10-19
To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
GDC-0449 - Basal Cell Nevus Syndrome, Gorlin Syndrome
Phase 2CompletedUCSF Benioff Children's Hospital Oakland412009-08-012021-01-11
A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients
Vehicle, LDE225 0.25%, LDE225 0.75% - Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Phase 2CompletedNovartis Pharmaceuticals182009-07-012015-11-03
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
tazarotene, placebo - Skin Carcinoma
Phase 2CompletedUCSF Benioff Children's Hospital Oakland342004-07-012016-02-11
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
tazarotene - Neoplastic Syndrome
Phase 2CompletedUCSF Benioff Children's Hospital Oakland362004-07-012020-10-29

Narrower conditions

Basal Cell Nevus Syndrome (12)  ·  Carcinoma, Basal Cell (9)  ·  Neoplasms (2)  ·  Bone Cysts, Aneurysmal (1)  ·  Fractures, Spontaneous (1)  ·  Medulloblastoma (1)  ·  Odontogenic Cysts (1)  ·  Recurrence (1)  ·  Skin Neoplasms (1)

Broader conditions

Cysts (14)  ·  Musculoskeletal Diseases (14)  ·  Bone Diseases (13)  ·  Jaw Cysts (13)  ·  Jaw Diseases (13)  ·  Stomatognathic Diseases (13)  ·  Abnormalities, Multiple (12)  ·  Bone Diseases, Developmental (12)  ·  Carcinoma (12)  ·  Congenital Abnormalities (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Genetic Diseases, Inborn (12)  ·  Neoplasms (12)  ·  Neoplasms by Histologic Type (12)

Interventions

HhAntag691 (3)  ·  Drug Evaluation (2)  ·  IPI-926 (2)  ·  gusacitinib (2)  ·  tazarotene (2)  ·  Aminolevulinic Acid (1)  ·  Carboplatin (1)  ·  Cyclophosphamide (1)  ·  Denosumab (1)  ·  Etoposide (1)  ·  Fluorouracil (1)  ·  Mental Status and Dementia Tests (1)  ·  Methotrexate (1)  ·  Surgical Procedures, Operative (1)  ·  Vincristine (1)

Sponsors

UCSF Benioff Children's Hospital Oakland (4)  ·  Ascend Biopharmaceuticals Ltd (2)  ·  Novartis Pharmaceuticals (2)  ·  PellePharm, Inc. (2)  ·  Children's Oncology Group (1)  ·  NYU College of Dentistry (1)  ·  Palvella Therapeutics, Inc. (1)  ·  Peking University People's Hospital (1)

Countries

United States (8)  ·  Australia (3)  ·  Austria (2)  ·  Canada (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Ervin Epstein, MD (5)  ·  David R. Bickers, MD (2)  ·  Gregory Siller (2)  ·  Brian L Schmidt, DDS, MD, PhD (1)  ·  Clement Leong, Ph.D (1)  ·  David Bickers, MD (1)  ·  John Lear, MD (1)  ·  Joyce Teng, MD (1)  ·  Lucie E Lafay-Cousin (1)  ·  Lynda Spelman (1)  ·  Rodney Sinclair (1)

Results publications

PMID 22670904, PMID 24441673, PMID 24623282, PMID 27838224

NIH funding

R01CA109584 (2), 2015 (1), U10CA098543 (1), U10CA180886 (1), U19CA081888 (1)